[1] |
ZHANG Yunuo, LI Ruibin, WANG Wei.
Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(26): 3264-3270.
|
[2] |
ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei.
Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy
[J]. Chinese General Practice, 2025, 28(26): 3307-3313.
|
[3] |
HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin.
Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer
[J]. Chinese General Practice, 2025, 28(26): 3276-3282.
|
[4] |
CHOU Xintong, PENG Hanyu, MA Hui, ZHANG Zhen, SU Xian, QIU Hongyan.
Maternal Preferences in Contraceptive Decision-making: an Analysis of Influencing Factors
[J]. Chinese General Practice, 2025, 28(26): 3294-3299.
|
[5] |
WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li.
Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation
[J]. Chinese General Practice, 2025, 28(26): 3271-3276.
|
[6] |
YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le.
Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural
[J]. Chinese General Practice, 2025, 28(25): 3137-3143.
|
[7] |
TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang.
Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level
[J]. Chinese General Practice, 2025, 28(25): 3096-3103.
|
[8] |
FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng.
Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases
[J]. Chinese General Practice, 2025, 28(25): 3144-3150.
|
[9] |
YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan.
Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes
[J]. Chinese General Practice, 2025, 28(24): 3053-3058.
|
[10] |
WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening.
Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention
[J]. Chinese General Practice, 2025, 28(24): 2985-2992.
|
[11] |
WU Yue, WANG Xuetong, KE Bilian.
Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors
[J]. Chinese General Practice, 2025, 28(23): 2908-2914.
|
[12] |
DING Zijun, ZHOU Nannan, LUO Xing, LUO Jieyu, HAO Wenjuan, ZHANG Chunjiang, JIN Xin, ZHAO Dan.
Cognitive Impairment in Patients on Maintenance Hemodialysis and Its Influencing Factors: a Multicenter Cross-sectional Study
[J]. Chinese General Practice, 2025, 28(23): 2885-2893.
|
[13] |
LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin.
Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2852-2860.
|
[14] |
WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei.
Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(23): 2846-2851.
|
[15] |
BAI Xue, CHEN Qianqian, LI Jie.
Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2841-2845.
|